Chiral separations using polymeric dipeptide surfactants: Effect of number of chiral centers and steric factors

Journal of Chromatography A

Volumn 858, Issue 2, 1999, Pages 219-227

  Haddadian, Fereshteh ^a   Billiot, Eugene J ^a   Shamsi, Shahab A ^b   Warner, Isiah M ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b GEORGIA STATE UNIVERSITY   (United States)

Author keywords

Enantiomer separation; Peptides; Pseudo stationary phases; Surfactants

Indexed keywords

1,1' BINAPHTHYL DERIVATIVE; ALPRENOLOL; AMINOGLUTETHIMIDE; GLUTETHIMIDE; LORAZEPAM; OXAZEPAM; OXPRENOLOL; PEPTIDE DERIVATIVE; PROPRANOLOL; SURFACTANT; TEMAZEPAM;

ARTICLE; CAPILLARY ELECTROPHORESIS; CHIRALITY; DRUG ISOLATION; ENANTIOMER; MICELLAR ELECTROKINETIC CHROMATOGRAPHY; PRIORITY JOURNAL; TECHNIQUE;

ADRENERGIC BETA-ANTAGONISTS; BENZODIAZEPINES; DIPEPTIDES; ELECTROPHORESIS, CAPILLARY; ETHERS; GLUTETHIMIDE; NAPHTHALENES; STEREOISOMERISM; SURFACE-ACTIVE AGENTS;

EID: 0032840765     PISSN: 00219673     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9673(99)00810-9     Document Type: Article

References (29)

1. Dobashi A., Hamada M. J. Chromatogr. A. 780:1997;179.
2. Shamsi S.A., Warner I.M. Electrophoresis. 18:1997;853.
3. Palmer C.P. J. Chromatogr. A. 780:1997;75.
4. Noctor T. Drug Stereochemistry. 2nd ed. 1993;Marcel Dekker, New York. Ch. 12.
5. Lelievre F., Gareil P., Jardy A. Anal. Chem. 69:1997;385.
6. Lelievre F., Gareil P., Bahaddi Y., Galons H. Anal. Chem. 69:1997;393.
7. Yowell G.G., Fazio S.D., Vivilecchia R.V. J. Chromatogr. A. 745:1996;73.
8. Haynes J.L., Shamsi S.A., O'Keeffe F., Darcy R., Warner I.M. J. Chromatogr. A. 803:1998;261.
9. O'Keeffe F., Shamsi S.A., Darcy R., Schwinte P., Warner I.M. Anal. Chem. 69:1997;4773.
10. Gasper M.P., Berthod A., Nair U.B., Armstrong D.W. Anal. Chem. 68:1996;2501.
11. Nair B.U., Armstrong D.W., Hinze L.W. Anal. Chem. 70:1998;1059.
12. Otsuka K., Karuhaka K., Higashimori M., Terabe S. J. Chromatogr. A. 680:1994;317.
13. Otuska K., Kawahara M., Kawaguchi Y., Hisamitsu K.T., Terabe S. J. Chromatogr. A. 652:1993;253.
14. Otuska K., Kawakami H., Tamaki W., Terabe S. J. Chromatogr. A. 716:1995;319.
15. Dobashi A., Hamada M., Dobashi Y., Yamaguchi J. Anal. Chem. 67:1995;3011.
16. Palmer C.P., Terabe S. Anal. Chem. 69:1997;1852.
17. Wang J., Warner I.M. Anal. Chem. 66:1994;933.
18. Shamsi S.A., Akbay C., Warner I.M. Anal. Chem. 70:1998;3078.
19. Palmer C.P., Tanaka N. J. Chromatogr. A. 792:1997;105.
20. Wang J., Warner I.M. J. Chromatogr. A. 711:1995;297.
21. Agnew-Heard K.A., Sanchez Pena M., Shamsi S.A., Warner I.M. Anal. Chem. 69:1997;958.
22. Shamsi S.A., Mocossay J., Warner I.M. Anal. Chem. 69:1997;2980.
23. Billiot E.J., Agbaria R.A., Thibodesux S., Shamsi S.A., Warner I.M. Anal. Chem. 70:1997;1375.
24. E.J. Billiot, S.A. Thibodesux, S.A. Shamsi, I.M. Warner, Anal. Chem., in press.
25. Billiot E.J., Agbaria R.A., Thibodesux S.A., Shamsi S.A., Warner I.M. Anal. Chem. 71:1999;1252.
26. E.J. Billiot, personal communication.
27. Israili Z.H. Wong S.H.Y. Therapeutic Drug Monitoring and Toxicology by Liquid Chromatography. Chromatographic Science Series. Vol. 32:1985;Marcel Dekker, New York. Ch. 13.
28. Crossley R. Chirality and the Biological Activity of Drugs. 1995;CRC Press, New York.
29. Francotte E. J. Chromatogr. A. 666:1994;565.